Page last updated: 2024-11-08

2,2,6,6-tetramethylpiperidine-n-oxide-4-amino-4-carboxylic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2,2,6,6-tetramethylpiperidine-N-oxide-4-amino-4-carboxylic acid: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID167486
CHEBI ID33228
MeSH IDM0112512

Synonyms (21)

Synonym
CHEBI:33228
toac
4-amino-4-carboxy-2,2,6,6-tetramethyl-1-piperidinyloxy
2,2,6,6-tetramethylpiperidine-n-oxide-4-amino-4-carboxylic acid
(4-amino-4-carboxy-2,2,6,6-tetramethylpiperidin-1-yl)oxidanyl
15871-57-5
4-amino-1-hydroxy-2,2,6,6-tetramethylpiperidine-4-carboxylic acid
2,2,6,6-tetramethylpiperidine-n-oxyl-4-amino-4-carboxylic acid
xdn8h1xm17 ,
nsc 239127
unii-xdn8h1xm17
FT-0675104
tempo-4-amino-4-carboxylic acid
4-amino-4-carboxy-2,2,6,6-tetramethylpiperidine 1-oxyl
2,2,6,6-tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic acid
toac [mi]
DTXSID70166501
AKOS028113174
1-piperidinyloxy,4-amino-4-carboxy-2,2,6,6-tetramethyl-
mfcd00800575
toac; 4-amino-4-carboxy-2,2,6,6-tetramethylpiperidine-1-oxyl
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
piperidinemonocarboxylic acidAny member of the class of piperidines in which one of the carbons of the piperidine ring is substituted by a carboxy group.
aminoxylsRadicals derived from hydroxylamines by removal of the hydrogen atom from the hydroxy group. The synonymous terms nitroxyl radicals and nitroxides erroneously suggest the presence of a nitro group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (64)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (1.56)18.7374
1990's8 (12.50)18.2507
2000's34 (53.13)29.6817
2010's18 (28.13)24.3611
2020's3 (4.69)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.44

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.44 (24.57)
Research Supply Index4.19 (2.92)
Research Growth Index5.63 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.44)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other65 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]